TUMOUR necrosis factor-a (TNF-) 
Introduction
we measured eosinophil cationic protein (ECP) in nasal secretions.
Tumour necrosis factor<z (TNF-cz)was identified as an anti-tumour cytokine derived from macrophages (M). So (1) fluids has been reported and recognized as an perennially persistent and recurrent nasal syrupimportant mediator in bronchial asthma. 8 toms consisting of sneezing attacks, watery nasal However, there have not been sufficient studies discharge and nasal obstruction; (2) positive to clarify the role of TNF-0t in nasal allergy. It These cytokines may take part in the network and modulate allergic inflammation of the nasal mucosa.
Eosinophil accumulation in the nasal mucosa is a hallmark of nasal allergy, and nonspecific hyperresponsiveness of the nasal mucosa is an important clinical feature of nasal allergy. Eosinophils predominantly release lipid mediators such as leukotriene C4 (EWe4) 19 and platelet activating factor (PAF) 2 as well as cytotoxic granule proteins such as major basic protein, ECP, eosinophil peroxidase and eosinophil derived neurotoxin. 21 Recent studies have suggested that eosinophils play an important role in the mechanism of mucosal nonspecific hyperresponsiveness. Therefore, eosinophil recruitment in the nasal mucosa is crucial in the pathogenesis of nasal allergy.
In the present study, TNF-cz was detected in nasal lavage fluid from patients with perennial nasal allergy. Bachert et a/. 22 reported that TNF-z increased in nasal lavage during immediate nasal response. Some previous studies have reported that this cytokine was detected or not detected in nasal lavages from nasal allergy patients. 23 
